GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESALF) » Definitions » Short-Term Debt

ESALF (Eisai Co) Short-Term Debt : $588 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Eisai Co Short-Term Debt?

Eisai Co's Short-Term Debt for the quarter that ended in Mar. 2025 was $588 Mil.

Eisai Co's quarterly Short-Term Debt increased from Sep. 2024 ($581 Mil) to Dec. 2024 ($775 Mil) but then declined from Dec. 2024 ($775 Mil) to Mar. 2025 ($588 Mil).

Eisai Co's annual Short-Term Debt declined from Mar. 2023 ($308 Mil) to Mar. 2024 ($164 Mil) but then increased from Mar. 2024 ($164 Mil) to Mar. 2025 ($588 Mil).

Eisai Co Short-Term Debt Historical Data

The historical data trend for Eisai Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Short-Term Debt Chart

Eisai Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 367.85 - 308.24 164.41 588.30

Eisai Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.41 - 581.20 775.47 588.30

Eisai Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Eisai Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Eisai Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESALF) » Definitions » Short-Term Debt
Comparable Companies
TSE:4506 TSE:4530 TSE:4540 TSE:4516 TSE:4887 TSE:4507 TSE:4551 TSE:4547 TSE:4553 TSE:4521 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
ESAIY:USA 4523:Japan EII:Germany
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Website
http://www.eisai.co.jp
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.